logo-loader

BATM Advanced gets boost as it unveils coronavirus diagnostics kit

Last updated: 08:40 27 Feb 2020 GMT, First published: 08:08 27 Feb 2020 GMT

BATM Advanced Communications Ltd - BATM Advanced unveils coronavirus diagnostics kit

BATM Advanced Communications Limited (LON:BVC) shares rose on Thursday as it revealed its Bio-Medical division has successfully developed a new diagnostics kit to detect the coronavirus.

The kit has undergone testing by several central laboratories and hospitals that have now verified its ability to diagnose COVID-19, added the medical device maker.

Production of the kit has already started and work is underway to adapt it for large scale production.

The kit, which supports all the Centers for Disease Control and Prevention (CDC) recommendations, has already received interest from customers in several countries

Zvi Marom, BATM’s chief executive, said: "We believe that the strategy we adopted in our Bio-Medical division is proving to be correct, especially in light of the current COVID-19 outbreak. We are able now to quickly provide diagnostic kits for any new pathogen that appears.

"Furthermore, we have already received extremely positive feedback and significant interest from several leading medical institutions that have started testing the first panel of Ador's NATlab solution and adding COVID-19 will greatly strengthen its appeal and value."

In early trade, BATM shares were 8.1% higher at 44.20p.

 -- Adds share price --

HANetf founder and co-CEO discusses shift to active management in ETF market

HANetf founder and co-CEO Hector McNeil tells Proactive's Stephen Gunnion about shifting trends in the exchange-traded fund (ETF) market in the United States, indicating a big move towards active management within ETFs. Despite the European market lagging behind the US by three to five years,...

12 hours, 33 minutes ago